WhaleWatch
Sign inGet started
Smart Money Alert
Biocon Limited logo

Biocon Limited

New PositionBlock Deal
BIOCONPharmaceuticalsMarket Cap₹60K Cr
Value
₹25.04 Cr
Shares
6,26,000
Price
₹400
Morgan Stanley
Morgan Stanley
Foreign Investor
The move

Morgan Stanley bought 626,000 shares of Biocon Limited for ₹25.04 Cr at ₹400.00 apiece in a block deal.

About Biocon Limited
Visit stock

A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.

About Morgan Stanley
Visit investor

US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.

Get the next move the moment it happens.
Follow Morgan Stanley and Biocon Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Biocon Limited shareholdersMorgan Stanley's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Biocon Limited
More moves in Biocon Limited
Kotak Mutual FundIncreased
Kotak Mutual Fund bought 12,77,000 shares of Biocon Limited for ₹49.16 Cr at ₹385.00 apiece in a block deal.
9 Sept 2026
Read more
Government Pension Fund Global (Norway)New position
Government Pension Fund Global (Norway) bought 6,500,02 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal on September 9, 2026.
9 Sept 2026
Read more
Edelweiss Mutual FundNew position
Edelweiss Mutual Fund bought 6,50,002 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal.
9 Sept 2026
Read more
Societe GeneraleNew position
Societe Generale bought 6.5 lakh shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal.
9 Sept 2026
Read more
Bajaj Allianz Life InsuranceNew position
Bajaj Allianz Life Insurance bought 6,500,022 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal.
9 Sept 2026
Read more
See all moves
Morgan Stanley
More moves by Morgan Stanley
Meesho Limited
Direction, size, price and stake change for this move, with what it means for the company.
23 Sept 2026. Sign in to see this move
Pine Labs LimitedNew position
Morgan Stanley bought 13,50,001 shares of Pine Labs Limited for ₹25.35 Cr at ₹187.75 apiece in a block deal.
PINELABS22 Sept 2026
Read more
Sri Lotus Developers and Realty LimitedNew position
Morgan Stanley bought 15 lakh shares of Sri Lotus Developers and Realty Limited for ₹30.26 Cr at ₹201.75 apiece in a block deal.
LOTUSDEV11 Sept 2026
Read more
Meesho LimitedNew position
Morgan Stanley bought 33 lakh shares of Meesho Limited for ₹68.08 Cr at ₹206.30 apiece in a block deal.
MEESHO3 Sept 2026
Read more
Pine Labs LimitedNew position
Morgan Stanley bought 24,48,742 shares of Pine Labs Limited for ₹37.98 Cr at ₹155.10 apiece in a block deal.
PINELABS2 Sept 2026
Read more
See all moves